Clinical Trials on Chronic Myeloproliferative Disorders in Australia

Total 5331 results

Kirby Institute
Bristol-Myers Squibb

Withdrawn

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism (HEPCOG-II)

Hepatitis C, Chronic

Australia
Smith & Nephew, Inc.

Completed

Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery

Hip Pain Chronic | Greater Trochanteric Pain Syndrome

Australia
La Trobe University
The Alfred; Austin Hospital, Melbourne Australia

Completed

Does Positive Expiratory Pressure Mask Therapy Improve Recovery From Acute Exacerbations of Chronic Obstructive Pulmonary Disease?

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive

Australia
Medical University of Graz

Completed

Neutrophil Function During Therapy With Protease Inhibitors in Chronic Hepatitis C

Chronic Hepatitis C

Austria
University of Sydney
National Health and Medical Research Council, Australia; Sydney South West... and other collaborators

Completed

PINOT Follow-up Study in End-stage Kidney Disease

Chronic Kidney Disease

Australia, United Kingdom
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
AOP Orphan Pharmaceuticals AG

Completed

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia (ARETA)

Essential Thrombocythaemia

Poland, Slovakia, Bulgaria, Russian Federation, Romania, Croatia, Lithuania, Austria, Ukraine
The University of New South Wales

Withdrawn

A Comparative Trial of TMS Approaches to Treating Depression

Depression

Australia
The University of New South Wales

Completed

Trial of Bilateral tDCS for Depression

Depression

Australia
AbbVie
Genentech, Inc.

Completed

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States, Australia
Medical University of Graz

Completed

Keyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)

Liver Cirrhosis | Chronic Hepatitis C

Austria
Celgene

Completed

A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

Myelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid Metaplasia

United States, Italy, United Kingdom, Austria, Spain
AbbVie
Genentech, Inc.

Active, not recruiting

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Non-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid Malignancies

United States, Australia
AbbVie

Active, not recruiting

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis (TRANSFORM-1)

Myelofibrosis (MF)

United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Spain, Sweden, Taiwan, Turkey and more
Compumedics Limited

Completed

Comparative Assessment of Compumedics Somfit Sleep Monitoring Device

Sleep-Disordered Breathing

Australia
University of Adelaide

Unknown

An Assessment of Fentanyl Dose Requirements in Opioid-maintained Individuals (FEN001)

Opioid Dependence

Australia
BeiGene

Recruiting

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditions

China, Australia
Genzyme, a Sanofi Company

Completed

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom, Australia, Denmark, France, Germany
Prim. Priv. Doz. Dr. Daniel Cejka
Amgen

Completed

A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients

End Stage Renal Disease

Austria
Murdoch Childrens Research Institute
University of Melbourne

Completed

Neurobehavioural Development of Infants Born <30 Weeks Gestational Age Between Birth and Five Years of Age (VIBeS-2)

Neurodevelopmental Disorders | Motor Activity | Developmental Coordination Disorder | Preterm Infant

Australia
The University of New South Wales

Completed

Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)

Bipolar Disorder

Australia
Mage Biologics
Alimentiv Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants

Ulcerative Colitis

Australia
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Medical University of Vienna

Completed

Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension

Sleep Disordered Breathing | Chronic Thromboembolic Pulmonary Hypertension

Austria
R3 Vascular Inc.

Recruiting

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia (MAGNITUDE-BTK)

Critical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening Ischemia

Australia
The University of Queensland
Princess Alexandra Hospital, Brisbane, Australia; Macquarie University, Australia

Recruiting

A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms

Gastrointestinal Diseases | Irritable Bowel Syndrome

Australia
Geron Corporation

Recruiting

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Myelofibrosis

United States, Australia, Italy, India, United Kingdom, Israel, Taiwan, Poland, Malaysia, Argentina, Spain, Turkey, Belgium, Germany, Austria, Brazil, Bulgaria, Colombia, Denmark, France, Georgia, Hungary, Korea, Republic of, Portugal, ... and more
University of California, San Diego
National Institutes of Health (NIH)

Recruiting

Frequency and E-field Enhancement of ITBS for Depression (FREED) (FREED)

Major Depressive Disorder

United States, Australia
The University of New South Wales
St George Hospital, Australia; Northside Clinic, Australia; The Melbourne Clinic... and other collaborators

Completed

Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT) (UB ECT)

Major Depressive Disorder

Australia
St Vincent's Hospital, Sydney

Completed

Cognitive Bias Modification (CBM) Via Imagery and Internet Cognitive Behavioural Therapy (iCBT) for Depression

Depression

Australia
Alishia Williams
The University of New South Wales

Completed

Cognitive Bias Modification (CBM) and Internet Cognitive Behavioural Therapy (iCBT) for Depression- A Randomised Controlled Trial

Depression

Australia
Northside Clinic, Australia

Terminated

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression

Depression

Australia
The University of New South Wales

Unknown

Depression and Transcranial Direct Current Stimulation (tDCS)

Depression

Australia
The University of New South Wales

Completed

Transcranial Electrical Stimulation (TES) for the Treatment of Depression.

Major Depression

Australia
The University of New South Wales

Completed

Open Pilot Trial of TES for Depression

Major Depression

Australia
Novartis Pharmaceuticals

Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Acute Lymphoblastic Leukemia (ALL) | Chronic Myelogenous Leukemia (CML) | Metastatic Gastrointestinal Stromal Tumors (GIST) | Receptor Tyrosine Kinase (KIT) Mutated Melanoma

Italy, United Kingdom, Canada, Singapore, Netherlands, France, Korea, Republic of, United States, Slovakia, Hungary, Russian Federation, Hong Kong, Spain, Israel, Sweden, Austria
Carina Biotech Limited

Recruiting

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Australia
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic Leukemia

United Kingdom, Spain, France, Australia
University of Sydney

Completed

Attention Training and Its Effects on Body Image Disturbance

Body Dissatisfaction | Eating Disorder Symptoms

Australia
Novartis Pharmaceuticals

Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Hypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)

United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
University of Melbourne
Beyondblue (The National Depression Initiative)

Completed

Three Model Care Pathways for Postnatal Depression

Postnatal Depression

Australia
Hoffmann-La Roche

Completed

A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer (ASCENT)

Colorectal Neoplasms

Australia
AbbVie

Active, not recruiting

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis (TRANSFORM-2)

Myelofibrosis (MF)

United States, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Puerto Rico, Russian Federation, Serbia, South... and more
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group

Completed

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Primary Central Nervous System Lymphoma

Australia, New Zealand
University of Melbourne
Pfizer

Completed

A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression

Depression | Anxiety

Australia
Universitaire Ziekenhuizen KU Leuven

Completed

Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis

End Stage Kidney Disease

Australia, Belgium
Royal Adelaide Hospital
University of Adelaide; University of South Australia; Saint Andrew's Hospital; Calvary North Adelaide Hospital

Completed

Intraperitoneal Local Anaesthetic in Bowel Surgery

Colorectal Disorders

Australia
The University of New South Wales
Icahn School of Medicine at Mount Sinai

Unknown

Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression (tDCS + CT)

Depression

Australia
Apreo Health, Inc.

Recruiting

First in Human Study to Assess an Implant to Treat Severe Emphysema (BREATHE-1)

Emphysema or COPD

Australia
Medical University of Vienna

Completed

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC) (AURIC)

Cirrhosis | Chronic Hepatitis C

Austria

Clinical Trials on Chronic Myeloproliferative Disorders in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations